InsidersTradesSigma
Track the Swedish Orphan Biovitrum AB (publ) stock price and the full directors' dealings record of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Swedish Orphan Biovitrum AB (publ) has recorded 69 insider filings. Market capitalisation: €153.6bn. The latest transaction was filed on 17 August 2026 (Purchase). Among the most active insiders: Guido Oelkers. Every trade is accessible without an account.
69
Insider Decl.
n/a
Thresholds
€34m
47 ops.
Buy Volume
€44m
22 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Swedish Orphan Biovitrum AB (publ) Buy (bullish), based on 12 analysts. Average price target: SEK 497.58.
32Σ signal
Fundamental score
Ranked 15,815 of 29,063 companies
49.6
score / 100
Value42
Quality57
FCF yld3.5%
Earn yld0.3%
EV/EBITDA15.4x
ROE3.4%
Gross mgn78%
Net mgn1.7%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 August 2026
Declarations69 total
56 shares@ SEK 441.997AktieISIN SE0000872095FI:csv-f5ac90647387c5924fe4
79,208 shares@ SEK 235.150.011% mcap8.0% of flowAktieISIN SE0000872095FI:csv-41b267e5dd511348c69c
79,208 shares@ SEK 467.410.022% mcap15.7% of flowAktieISIN SE0000872095FI:csv-3a84574e01f4e8d89100
97,515 shares@ SEK 235.150.014% mcap30.6% of flowAktieISIN SE0000872095FI:csv-4397a2950910a524d35e
97,515 shares@ SEK 474.2560.028% mcap61.7% of flowAktieISIN SE0000872095FI:csv-d325c993227e4ce0fc1a
100,000 shares@ SEK 464.000.028% mcap18.6% of flowAktieISIN SE0000872095FI:csv-58629e5394c9e92ae259
100,000 shares@ SEK 235.150.014% mcap9.4% of flowAktieISIN SE0000872095FI:csv-5dced926b59f6a0677d6
100,000 shares@ SEK 235.150.014% mcap9.4% of flowAktieISIN SE0000872095FI:csv-85327730eb69365abdb2
100,000 shares@ SEK 457.400.028% mcap18.4% of flowAktieISIN SE0000872095FI:csv-0c7c6f02c32b9cb77747
37,292 shares@ SEK 457.34AktieISIN SE0000872095FI:csv-8f837d79d423613b12cb
37,292 shares@ SEK 235.150.0054% mcap22.4% of flowAktieISIN SE0000872095FI:csv-1fee1526e5a8d8c0baa7
100,000 shares@ SEK 457.400.028% mcap25.5% of flowAktieISIN SE0000872095FI:csv-2ac200aeb164b225c8ba
100,000 shares@ SEK 235.150.014% mcap13.1% of flowAktieISIN SE0000872095FI:csv-ecb8aa0a04259afdad05
100,000 shares@ SEK 457.400.028% mcap25.5% of flowAktieISIN SE0000872095FI:csv-3700241e2fa5f3f12862
100,000 shares@ SEK 235.150.014% mcap13.1% of flowAktieISIN SE0000872095FI:csv-50f21d0ebcde3c56cc35
37,292 shares@ SEK 457.340.010% mcap56.1% of flowAktieISIN SE0000872095FI:csv-c9e632e20944582005e3
37,292 shares@ SEK 235.150.0054% mcap28.8% of flowAktieISIN SE0000872095FI:csv-e11729f2737e82c30a59
10,050 shares@ SEK 456.790.0028% mcap15.1% of flowAktieISIN SE0000872095FI:csv-1915fbd0bec313c90432
66,702 shares@ SEK 235.150.0098% mcap34.1% of flowAktieISIN SE0000872095FI:csv-3e1808fa0bee48e0cf39
66,702 shares@ SEK 454.44390.019% mcap50.0% of flowAktieISIN SE0000872095FI:csv-efd6f5b08a06faeb38c4
66,702 shares@ SEK 454.44390.019% mcap50.0% of flowAktieISIN SE0000872095FI:csv-3bdc92b515b6f5eb47f3
57,232 shares@ SEK 455.670.016% mcap48.8% of flowAktieISIN SE0000872095FI:csv-9f1665f9f78b3849460f
57,232 shares@ SEK 235.150.0083% mcap25.1% of flowAktieISIN SE0000872095FI:csv-6997cebafab9e7b5f0d6
61,936 shares@ SEK 457.04720.018% mcap46.9% of flowAktieISIN SE0000872095FI:csv-f016de64ea4c3f364b85
61,936 shares@ SEK 235.150.0090% mcap24.1% of flowAktieISIN SE0000872095FI:csv-c581b4c1a89c672b00d4
25 of 69 declarations
关于 Swedish Orphan Biovitrum AB (publ)
Swedish Orphan Biovitrum AB (publ) 是一家瑞典制药公司，专注于开发罕见疾病治疗方法。该公司在斯德哥尔摩证券交易所上市，股票代码为 XSTO。